Perspectives in Biology and Medicine

abstract:

Human germline genetic modification has long been a controversial topic. Until recently it remained largely a hypothetical debate: whether one accepted or opposed the idea in principle, it was not only too risky but impractical to execute in reality. With the advent of genome editing technologies, however, heritable modifications to the human genome became a much more concrete possibility; nonetheless, the consensus has to date remained that human heritable genome editing is not yet safe enough for clinical application. The announcement of the birth of two genome-edited babies in late 2018, therefore, was condemned almost universally as premature, irresponsible, and dangerous. But what does responsibility require, and from whom? How should risk and precaution be balanced in assessing heritable genome editing, and against what alternatives? This paper reexamines commonly held assumptions about risk and responsibility with respect to human genome editing and argues that the precautionary approach that has so far been favored is not well justified, that the risks of heritable versus somatic genome editing should be reassessed, and that a fuller account of responsibility—scientific, social, and global—is required for the ethical governance of genome editing.